Article Details
Retrieved on: 2018-03-07 21:52:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div>A consortium of leading global investors like Temasek and <b>Sequoia Capital</b> China have joined the $90-million Series A financing round of Shanghai-based biotech startup, JW Therapeutics, the companies announced on March 7. Others investors who joined the round include YuanMing Capital, Oriza ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here